EMA Withdrawn: Intrinsa (testosterone) — Warner Chilcott UK Ltd.

View source ↗

Summary

EMA withdrew Intrinsa, a testosterone product for sexual dysfunction, from the market in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sexual Dysfunction

Drugs mentioned

• Intrinsa (testosterone)

Snippet

Status: Withdrawn. Therapeutic area: Sexual Dysfunctions, Psychological. MAH: Warner Chilcott UK Ltd.. Decision date: 25/05/2012